These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. In vitro chemotherapy sensitivity testing for genitourinary malignancies. Lieber MM Prog Clin Biol Res; 1984; 153():51-65. PubMed ID: 6382286 [No Abstract] [Full Text] [Related]
9. Other chemotherapy regimens including mitoxantrone and suramin. Siu LL; Moore MJ Semin Urol Oncol; 1997 Feb; 15(1):20-7. PubMed ID: 9050136 [TBL] [Abstract][Full Text] [Related]
10. Cancer and leukemia group B breast committee: decades of progress and plans for the future. Hudis CA; Winer EP Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3576s-80s. PubMed ID: 16740788 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the serum lysozyme level as a further parameter for predicting hematological tolerance in patients treated with cytostatic chemotherapy. Study of 134 cases]. Neretto G; Agricola R; Giovanelli E; Poccardi G; Pellerito R; Furno F; Martinetto P; Pellegrino S; Daglio C; Tondolo M Recenti Prog Med; 1980 Oct; 69(4):431-57. PubMed ID: 7006015 [No Abstract] [Full Text] [Related]
12. Pegfilgrastim: evidence in support of its use with cytotoxic chemotherapy. Ng R; Green MD Expert Rev Anticancer Ther; 2005 Aug; 5(4):585-90. PubMed ID: 16111460 [TBL] [Abstract][Full Text] [Related]